| 基于微信平台的多终端交互式药品审批新模式 |
| |
| 引用本文： | 韩秋君,罗正伟.基于微信平台的多终端交互式药品审批新模式[J].医学信息学杂志,2018,39(1):60-63. |
| |
| 作者姓名： | 韩秋君 罗正伟 |
| |
| 作者单位： | 镇江市第一人民医院信息中心 镇江 212000,医利捷(上海)信息科技有限公司 上海 200000 |
| |
| 摘 要： | 以镇江市第一人民医院为例，分析基于微信平台开展多终端交互式药品审批的优势，从逻辑架构、物理架构以及业务流程设计3个方面阐述该模式的实现方式，指出该模式可有效实现药品混合审批工作的信息化管理。
|
| 关 键 词： | 微信企业号 药品审批 移动审批 身份认证 |
| 收稿时间： | 2017/11/20 0:00:00 |
A New Model of Multi-Terminal and Interractive Drug Approval Based on WeChat Platform |
| |
| HAN QIU-jun and LUO Zheng-wei.A New Model of Multi-Terminal and Interractive Drug Approval Based on WeChat Platform[J].Journal of Medical Informatics,2018,39(1):60-63. |
| |
| Authors: | HAN QIU-jun and LUO Zheng-wei |
| |
| Institution: | Information Center of Zhengjiang First People''s Hospital, Zhenjiang 212000, China and Medical Litye(Shanghai) Information Technology Co. Ltd., Shanghai 200000, China |
| |
| Abstract: | Taking Zhenjiang First Peopls''s Hospital as an example,the paper analyzes the advantage of mulit-terminal and interactive durg approval based on WeChat platform,dilates upon realization method of the mode from the three aspects of logic architecture,physical archtecture and business process and poinst out that the mode is able to realize informatization management of the mixed approval of drugs. |
| |
| Keywords: | WeChat enterprise Drug approval Mobile approval Identity certification |
|
| 点击此处可从《医学信息学杂志》浏览原始摘要信息 |
| 点击此处可从《医学信息学杂志》下载免费的PDF全文 |
